CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
Irvine, CA, July 7, 2021 - Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its collaboration regarding an Investigator Initiated Trial (IIT) with Otto-von-Guericke-University Magdeburg, Medical faculty has obtained approval from the ethics committee, and from the responsible Competent Authority (BfArM), in Germany. CLS and the Magdeburg medical team will now proceed with the previously announced IIT regarding MRI-Ultrasound,